The Senate Committee on Health, Education, Labor and Pensions grilled Novo Nordisk’s CEO Lars Fruergaard Jørgensen on the company’s high price for its weight loss drugs Ozempic and Wegovy in the United States compared to other countries.
Jørgensen nev…
